🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/12/2018 | 0,5248 USD |
| 14/09/2018 | 0,4580 USD |
| 14/06/2018 | 0,4580 USD |
| 14/03/2018 | 0,4580 USD |
| 14/12/2017 | 0,4580 USD |
| 14/09/2017 | 0,4485 USD |
| 13/06/2017 | 0,4485 USD |
| 13/03/2017 | 0,4485 USD |
| 13/12/2016 | 0,4485 USD |
| 13/09/2016 | 0,4389 USD |
| 13/06/2016 | 0,4389 USD |
| 11/03/2016 | 0,4389 USD |
| 11/12/2015 | 0,4389 USD |
| 11/09/2015 | 0,4294 USD |
| 11/06/2015 | 0,4294 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/09/1974 | 1,60 | 1,60 | 1,57 | 1,60 | -1,63% | 1,87% | 1.954.310 |
| 03/09/1974 | 1,68 | 1,70 | 1,62 | 1,62 | -3,54% | 4,53% | 1.146.931 |
| 30/08/1974 | 1,62 | 1,69 | 1,62 | 1,68 | +4,31% | 4,28% | 1.580.803 |
| 29/08/1974 | 1,57 | 1,62 | 1,57 | 1,61 | +2,52% | 2,94% | 1.343.117 |
| 28/08/1974 | 1,57 | 1,62 | 1,56 | 1,57 | +0,43% | 4,02% | 1.573.258 |
| 27/08/1974 | 1,56 | 1,59 | 1,55 | 1,57 | +0,21% | 2,75% | 1.411.027 |
| 26/08/1974 | 1,53 | 1,60 | 1,52 | 1,56 | +2,38% | 4,77% | 2.248.589 |
| 23/08/1974 | 1,55 | 1,57 | 1,53 | 1,53 | -1,50% | 2,99% | 999.792 |
| 22/08/1974 | 1,56 | 1,57 | 1,54 | 1,55 | -0,63% | 1,92% | 2.591.914 |
| 21/08/1974 | 1,56 | 1,59 | 1,55 | 1,56 | -0,21% | 2,54% | 894.154 |
| 20/08/1974 | 1,55 | 1,57 | 1,52 | 1,56 | +0,64% | 2,99% | 1.878.854 |
| 19/08/1974 | 1,59 | 1,60 | 1,54 | 1,55 | -2,29% | 3,55% | 3.048.422 |
| 16/08/1974 | 1,64 | 1,65 | 1,59 | 1,59 | -2,83% | 3,65% | 2.693.779 |
| 15/08/1974 | 1,62 | 1,64 | 1,62 | 1,64 | +0,81% | 1,23% | 1.641.168 |
| 14/08/1974 | 1,69 | 1,70 | 1,62 | 1,62 | -3,92% | 4,52% | 1.509.120 |
| 13/08/1974 | 1,74 | 1,74 | 1,69 | 1,69 | -2,67% | 3,05% | 1.618.531 |
| 12/08/1974 | 1,74 | 1,78 | 1,73 | 1,74 | -0,19% | 2,67% | 660.240 |
| 09/08/1974 | 1,76 | 1,76 | 1,73 | 1,74 | -1,68% | 1,88% | 916.790 |
| 08/08/1974 | 1,83 | 1,83 | 1,74 | 1,77 | -3,26% | 4,71% | 1.226.160 |
| 07/08/1974 | 1,79 | 1,83 | 1,77 | 1,83 | +2,22% | 3,15% | 1.109.203 |
| 06/08/1974 | 1,78 | 1,83 | 1,78 | 1,79 | +3,25% | 2,61% | 2.274.998 |
| 05/08/1974 | 1,73 | 1,75 | 1,70 | 1,73 | +0,38% | 3,07% | 1.803.398 |
| 02/08/1974 | 1,78 | 1,78 | 1,73 | 1,73 | -3,16% | 3,16% | 1.399.709 |
| 01/08/1974 | 1,78 | 1,80 | 1,76 | 1,78 | +0,37% | 2,24% | 1.143.158 |
| 31/07/1974 | 1,76 | 1,78 | 1,75 | 1,78 | +0,75% | 1,69% | 1.169.568 |
| 30/07/1974 | 1,82 | 1,82 | 1,74 | 1,76 | -3,10% | 4,37% | 2.640.960 |
| 29/07/1974 | 1,86 | 1,86 | 1,80 | 1,82 | -3,18% | 3,20% | 3.086.150 |
| 26/07/1974 | 1,92 | 1,92 | 1,88 | 1,88 | -2,24% | 1,90% | 2.014.675 |
| 25/07/1974 | 1,95 | 1,95 | 1,91 | 1,92 | -1,36% | 1,87% | 2.093.904 |
| 24/07/1974 | 1,99 | 1,99 | 1,94 | 1,95 | -3,29% | 2,33% | 2.316.499 |